Literature DB >> 27407520

Amplatzer Device closure of Atrial Septal Defects and Patent Ductus Arteriosus: Initial Experience.

J S Dugal1, V Jetley1, Charanjit Singh2, S K Datta3, J S Sabharwal1, Sunil Sofat4.   

Abstract

Surgical closure of Atrial Septal Defects (ASD) and Patent Ductus Arteriosus (PDA) can be performed successfully with low mortality. However, the morbidity associated with general anaesthesia, thoracotomy, cardiopulmonary bypass, postoperative monitoring in the intensive care unit, several days of hospital stay and the requirement of blood products is considerable. The expense associated with this morbidity, operative scar and the psychologic trauma to the patient and parents are additional disadvantages of surgery. Hence, the closure of these defects by transcatheter methods with various devices has been evaluated worldwide. We report the initial experience at our centre with closure of secundum ASDs and large PDAs with the Amplatzer Septal Occluder and Amplatzer Duct Occluder.

Entities:  

Keywords:  Amplatzer device; Large Patent Ductus Arteriosus; Secundum Atrial Septal Defects

Year:  2011        PMID: 27407520      PMCID: PMC4923623          DOI: 10.1016/S0377-1237(03)80011-4

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  25 in total

1.  Closure of persistent ductus arteriosus without thoracotomy.

Authors:  W Porstmann; L Wierny; H Warnke
Journal:  Ger Med Mon       Date:  1967-06

2.  Secundum atrial septal defect. Nonoperative closure during cardiac catheterization.

Authors:  T D King; S L Thompson; C Steiner; N L Mills
Journal:  JAMA       Date:  1976-06-07       Impact factor: 56.272

3.  Closure of atrial septal defects with the Amplatzer occlusion device: preliminary results.

Authors:  B D Thanopoulos; C V Laskari; G S Tsaousis; A Zarayelyan; A Vekiou; G S Papadopoulos
Journal:  J Am Coll Cardiol       Date:  1998-04       Impact factor: 24.094

4.  Transcatheter closure of secundum atrial septal defects with the atrial septal defect occlusion system (ASDOS): initial experience in children.

Authors:  G Hausdorf; M Schneider; B Franzbach; C Kampmann; K Kargus; B Goeldner
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

5.  Double-umbrella device for transvenous closure of patent ductus arteriosus and atrial septal defect: first experience.

Authors:  U U Babic; S Grujicic; Z Popovic; Z Djurisic; M Vucinic; P Pejcic
Journal:  J Interv Cardiol       Date:  1991       Impact factor: 2.279

6.  Transcatheter closure with single or multiple Gianturco coils of patent ductus arteriosus in infants weighing < or = 8 kg: retrograde versus antegrade approach.

Authors:  Z M Hijazi; T R Lloyd; R H Beekman; R L Geggel
Journal:  Am Heart J       Date:  1996-10       Impact factor: 4.749

7.  Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System.

Authors:  W J Rashkind; C E Mullins; W E Hellenbrand; M A Tait
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

8.  International experience with secundum atrial septal defect occlusion by the buttoned device.

Authors:  P S Rao; E B Sideris; G Hausdorf; C Rey; T R Lloyd; R H Beekman; A M Worms; F Bourlon; E Onorato; M Khalilullah
Journal:  Am Heart J       Date:  1994-11       Impact factor: 4.749

9.  Monodisk: device for percutaneous transcatheter closure of cardiac septal defects.

Authors:  D Pavcnik; K C Wright; S Wallace
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Sep-Oct       Impact factor: 2.740

10.  Percutaneous closure of the small patent ductus arteriosus using occluding spring coils.

Authors:  J W Moore; L George; S E Kirkpatrick; J W Mathewson; R L Spicer; K Uzark; A Rothman; P A Cambier; M C Slack; W C Kirby
Journal:  J Am Coll Cardiol       Date:  1994-03-01       Impact factor: 24.094

View more
  1 in total

1.  Patent ductus arteriosus device embolization.

Authors:  K Iqbal; Sm Ali; Na Tramboo; Aa Lone; S Kaul; N Kaul; I Hafiz
Journal:  Images Paediatr Cardiol       Date:  2011-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.